BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Alliance of ALS/MND Associations - ECPv6.8.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:International Alliance of ALS/MND Associations
X-ORIGINAL-URL:https://www.als-mnd.org
X-WR-CALDESC:Events for International Alliance of ALS/MND Associations
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250319T080000
DTEND;TZID=America/Toronto:20250319T090000
DTSTAMP:20261013T231547
CREATED:20250220T162114Z
LAST-MODIFIED:20250220T162114Z
UID:18273-1742371200-1742374800@www.als-mnd.org
SUMMARY:Webinar from the International Alliance: ALS/MND Platform Trials Update
DESCRIPTION:ALS/MND PLATFORM TRIALS UPDATE\n \n19 March 8 am ET\nRegistration: https://us02web.zoom.us/webinar/register/WN_GEOgomftSVOcV0woGWug4g#/registration\nWe will have captions available\n \nThis webinar will provide information on ALS/MND platform trials. We will hear from HEALEY\, EXPERTS ALS and SMART. They will update us on their approach\, recruitment\, trial eligibility and their latest news.
URL:https://www.als-mnd.org/event/webinar-from-the-international-alliance-als-mnd-platform-trials-update/
LOCATION:Online
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250331T130000
DTEND;TZID=America/Toronto:20250331T140000
DTSTAMP:20261013T231547
CREATED:20250303T131846Z
LAST-MODIFIED:20250303T131846Z
UID:18299-1743426000-1743429600@www.als-mnd.org
SUMMARY:Webinar from Les Turner ALS Foundation: Observational Studies Help in the Quest for Effective ALS Therapies
DESCRIPTION:About the Program \nIn this talk Dr. Berry will discuss the aims\, design considerations\, and implementation of observational studies\, highlighting the many ways observational studies hastened drug development and can create resources that aid the ALS community in the present and for years to come. \nAbout the Speaker \nDr. Berry leads the Massachusetts General Hospital Division of ALS and Motor Neuron Diseases. He is an active clinician and ALS clinical researcher\, with a focus on biomarker development and ALS clinical trial methodology. He oversees a large biorepository\, collecting\, storing and sharing blood\, DNA\, and spinal fluid and accompanying patient information\, which allows researchers around the globe to conduct critical research identifying biomarkers of ALS and developing novel therapeutics. He also leads projects developing digital endpoints for ALS trials that will help increase the objective data for trials while decreasing the burden on trial participants. Finally\, he is deeply committed to developing novel therapeutics by translating discoveries in the lab into clinical trials and leading clinical trials that will transform our approach to care in ALS. \nDr. Berry also oversees and leads out the clinic at the Healey Center for ALS\, caring for patients and helping to build and lead the multidisciplinary care team. He helped found the Telemedicine for People with ALS (TelePALS) program\, the ALS House Call Program and the Parenting at a Challenging Time (PACT) programs within the clinic. \nThe Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to the Gilbert & Jacqueline Fern Foundation\, Mitsubishi Tanabe Pharma America\, & Biogen for sponsoring this webinar. \nLink to register
URL:https://www.als-mnd.org/event/webinar-from-les-turner-als-foundation-observational-studies-help-in-the-quest-for-effective-als-therapies/
LOCATION:Online
CATEGORIES:Webinar
ORGANIZER;CN="Les Turner ALS Foundation":MAILTO:info@lesturnerals.org
END:VEVENT
END:VCALENDAR